Access an interactive webinar to learn how Zephyr AI:
- Empowers their small team of data scientists to leverage their expertise to manage custom code sets, generate their own mappings, and build their own mapping algorithms
- Operationalizes workflows with a sustainable architecture and process for future growth
- Delivers value faster to their customers by getting to production in less than 30 days – leading to better outcomes and lower costs
We also cover strategies for improving data quality at your healthcare organization and what to expect from a best-of-breed terminology management solution like Rhapsody Semantic.
Meet the speakers:
Amy Sheide, VP, data platform and partnerships, Zephyr AI
Amy Sheide is the vice president of data platform and partnerships at Zephyr AI. Amy is responsible for the development and implementation of Zephyr AI’s biomedical data acquisition making data available for their ML/AI models. She turns data assets into value-add data and analytics, ensuring its quality and completeness. Amy leads a team of clinical data managers who build and execute data mappings and partners with external organizations to deliver value that will improve healthcare outcomes. Amy is also a nurse, with over 10 years of bedside experience in the ICU.
Camilla Frejlev Bæk, product owner, terminology, Rhapsody
Camilla is the product owner of Rhapsody Semantic, a terminology platform for all medical code sets. She is passionate about using and managing healthcare data effectively to improve overall health and in that setting also uses artificial intelligence to solve problems within healthcare. She is highly skilled in semantic interoperability and FHIR and has been involved in several international projects at Rhapsody. Camilla is skilled in all healthcare terminologies and classifications such as SNOMED CT, ICD-10, ICD11, and LOINC.
Shelley Wehmeyer, senior director, product and partner marketing, Rhapsody
Shelley dedicates her career to simplifying the complexities of health and social care delivery around the world with technology. Whether in the context of navigating the requirements of a new market, launching a new product, or enabling client-facing teams and clients on product strategy, the most rewarding part of Shelley’s experience is the ability to bring together cross-functional, cross-organizational teams to a common goal — doing what is best for the patient and the clinician.
